A supplement that combines antioxidants with zinc and copper is a relatively inexpensive and effective means of halting the progression of a certain type of degenerative eye disease, concludes research published online in the British Journal of Ophthalmology. Given the costs and side effects of the current range of drugs used to treat the ‘wet’ form...
Tag: <span>AMD</span>
Post
Findings suggest underdiagnosis of AMD not uncommon in primary eye care
Approximately 25 percent of eyes deemed to be normal based on dilated eye examination by a primary eye care ophthalmologist or optometrist had macular characteristics that indicated age-related macular degeneration (AMD), according to a study published by JAMA Ophthalmology. Approximately 14 million Americans have AMD and, as the baby boomer population ages, this public health problem...
Post
Mixed results for stem cell treatments of AMD
(HealthDay)—Stem cells may offer new hope for patients with age-related macular degeneration, but that promise can come with some risks, according to research published in the March 17 issue of the New England Journal of Medicine. One report details a legitimate effort to restore the sight of a 77-year-old Japanese woman with macular degeneration using stem...
Post
Repeated eye injections for age-related macular degeneration associated with increased risk for glaucoma
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published online by JAMA Ophthalmology. The advent of intravitreous (in the vitreous, the fluid behind the lens in the eye) anti-vascular endothelial growth factor (VEGF) injections to...
- 1
- 2